Michael E. Baser

2.9k total citations
35 papers, 2.0k citations indexed

About

Michael E. Baser is a scholar working on Neurology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Michael E. Baser has authored 35 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Neurology, 19 papers in Epidemiology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Michael E. Baser's work include Neurofibromatosis and Schwannoma Cases (23 papers), Meningioma and schwannoma management (19 papers) and Soft tissue tumors and treatment (7 papers). Michael E. Baser is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (23 papers), Meningioma and schwannoma management (19 papers) and Soft tissue tumors and treatment (7 papers). Michael E. Baser collaborates with scholars based in United States, United Kingdom and Canada. Michael E. Baser's co-authors include D. Gareth Evans, Jan M. Friedman, Harry Joe, James E. Gillespie, Richard Ramsden, Andrew J. Wallace, Stefan-M. Pulst, H. Rao Gattamaneni, Saba Sharif and Jillian M. Birch and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and PEDIATRICS.

In The Last Decade

Michael E. Baser

35 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael E. Baser United States 22 1.4k 994 335 264 249 35 2.0k
Romano Tenconi Italy 35 469 0.3× 325 0.3× 321 1.0× 147 0.6× 396 1.6× 122 3.5k
Raymond V. Randall United States 26 188 0.1× 467 0.5× 113 0.3× 75 0.3× 124 0.5× 57 2.2k
Yong Ko South Korea 19 391 0.3× 285 0.3× 48 0.1× 48 0.2× 218 0.9× 54 1.6k
Claire Alapetite France 27 527 0.4× 414 0.4× 65 0.2× 23 0.1× 663 2.7× 83 2.4k
Adrian Daly Belgium 33 388 0.3× 945 1.0× 102 0.3× 13 0.0× 106 0.4× 149 4.1k
Tsutomu Inaoka Japan 16 334 0.2× 136 0.1× 105 0.3× 80 0.3× 76 0.3× 55 868
Are Helseth Norway 17 223 0.2× 307 0.3× 33 0.1× 39 0.1× 197 0.8× 25 783
Lauren Fishbein United States 22 379 0.3× 319 0.3× 58 0.2× 16 0.1× 147 0.6× 61 2.1k
Fan Hu China 24 190 0.1× 240 0.2× 27 0.1× 67 0.3× 106 0.4× 82 1.5k
Tomasz Bednarczuk Poland 29 256 0.2× 163 0.2× 83 0.2× 68 0.3× 41 0.2× 125 2.5k

Countries citing papers authored by Michael E. Baser

Since Specialization
Citations

This map shows the geographic impact of Michael E. Baser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Baser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Baser more than expected).

Fields of papers citing papers by Michael E. Baser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Baser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Baser. The network helps show where Michael E. Baser may publish in the future.

Co-authorship network of co-authors of Michael E. Baser

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Baser. A scholar is included among the top collaborators of Michael E. Baser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Baser. Michael E. Baser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Man, Kenneth K. C., Shibani Nicum, Rowan Miller, et al.. (2024). The impact of inter-cycle treatment delays on overall survival in patients with advanced-stage ovarian cancer. The Oncologist. 29(11). e1532–e1539. 2 indexed citations
2.
Kipps, Emma, Kenneth K. C. Man, Rebecca Roylance, et al.. (2024). The impact of inter-cycle treatment delays on 5-year all-cause mortality in early-stage breast cancer: A retrospective cohort study. European Journal of Cancer. 210. 114301–114301. 4 indexed citations
3.
Baser, Michael E., Jan M. Friedman, Harry Joe, et al.. (2011). Empirical development of improved diagnostic criteria for neurofibromatosis 2. Genetics in Medicine. 13(6). 576–581. 55 indexed citations
4.
Baser, Michael E., Lisa Kuramoto, Harry Joe, et al.. (2004). Genotype-Phenotype Correlations for Nervous System Tumors in Neurofibromatosis 2: A Population-Based Study. The American Journal of Human Genetics. 75(2). 231–239. 86 indexed citations
5.
Baser, Michael E., Jan M. Friedman, Dana Aeschliman, et al.. (2002). Predictors of the Risk of Mortality in Neurofibromatosis 2. The American Journal of Human Genetics. 71(4). 715–723. 147 indexed citations
6.
Lee, Frank, et al.. (2000). Detection of novelNF2 mutations by an RNA mismatch cleavage method. Human Mutation. 15(5). 474–478. 7 indexed citations
7.
Hung, Gene, et al.. (2000). Neurofibromatosis 2 Phenotypes and Germ-Line NF2 Mutations Determined by an RNA Mismatch Method and Loss of Heterozygosity Analysis in NF2 Schwannomas. Cancer Genetics and Cytogenetics. 118(2). 167–168. 19 indexed citations
8.
Baser, Michael E. & D. Gareth Evans. (2000). Lack of sex‐ratio distortion in neurofibromatosis 2. American Journal of Medical Genetics. 95(3). 292–292. 2 indexed citations
9.
Ragge, Nicola, Michael E. Baser, Vincent M. Riccardi, & Rena E. Falk. (1997). The ocular presentation of neurofibromatosis 2. Eye. 11(1). 12–18. 37 indexed citations
10.
Baser, Michael E., et al.. (1996). Phenotypic variability in monozygotic twins with neurofibromatosis 2. American Journal of Medical Genetics. 64(4). 563–567. 32 indexed citations
11.
Scoles, Daniel R., Michael E. Baser, & Stefan-M. Pulst. (1996). A missense mutation in the neurofibromatosis 2 gene occurs in patients with mild and severe phenotypes. Neurology. 47(2). 544–546. 23 indexed citations
12.
Ragge, Nicola, Michael E. Baser, Alex Nechiporuk, et al.. (1995). Ocular Abnormalities in Neurofibromatosis 2. American Journal of Ophthalmology. 120(5). 634–641. 67 indexed citations
13.
Merel, P., Khê Hoang‐Xuan, Marc Sanson, et al.. (1995). Screening for germ‐line mutations in the NF2 Gene. Genes Chromosomes and Cancer. 12(2). 117–127. 107 indexed citations
14.
Sainz, Jesús, et al.. (1994). Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Human Molecular Genetics. 3(6). 885–891. 100 indexed citations
15.
Rothman, Nathaniel, D. Patrick Ford, Michael E. Baser, et al.. (1991). Pulmonary Function and Respiratory Symptoms in Wildland Firefighters. Journal of Occupational and Environmental Medicine. 33(11). 1163–1167. 72 indexed citations
16.
Bascom, Rebecca, et al.. (1990). Elevated Serum IgE, Eosinophilia, and Lung Function in Rubber Workers. Archives of Environmental Health An International Journal. 45(1). 15–19. 5 indexed citations
17.
Kennedy, Thomas P., Ronald F. Dodson, N. V. Rao, et al.. (1989). Dusts causing pneumoconiosis generate OH and produce hemolysis by acting as fenton catalysts. Archives of Biochemistry and Biophysics. 269(1). 359–364. 82 indexed citations
18.
Bascom, Rebecca, et al.. (1988). Eosinophilia, Respiratory Symptoms and Pulmonary Infiltrates in Rubber Workers. CHEST Journal. 93(1). 154–158. 6 indexed citations
19.
Carel, Rafael S., Melvyn S. Tockman, & Michael E. Baser. (1988). Smoking, Leukocyte Count, and Ventilatory Lung Function in Working Men. CHEST Journal. 93(6). 1137–1143. 16 indexed citations
20.
Assennato, Giorgio, et al.. (1986). Sperm Count Suppression without Endocrine Dysfunction in Lead-Exposed Men. Archives of Environmental Health An International Journal. 41(6). 387–390. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Romano Tenconi Breakdown of academic impact, for papers by Raymond V. Randall Breakdown of academic impact, for papers by Yong Ko Breakdown of academic impact, for papers by Claire Alapetite Breakdown of academic impact, for papers by Adrian Daly Breakdown of academic impact, for papers by Tsutomu Inaoka Breakdown of academic impact, for papers by Are Helseth Breakdown of academic impact, for papers by Lauren Fishbein Breakdown of academic impact, for papers by Fan Hu Breakdown of academic impact, for papers by Tomasz Bednarczuk
Rankless by CCL
2026